Home / Transcripts / Gladstone Capital Corporation (GLAD) · November 18, 2026

Gladstone Capital Corporation (GLAD) Earnings Call Transcript

November 18, 2026

NASDAQ US Financials Capital Markets earnings 47 min

Earnings Call Speaker Segments

David Gladstone executive
#1

Thanks — this is David Gladstone, speaking on the year-end call. We've enjoyed solid years and solid quarters, and everything at the company appears to be in good shape. We'll begin with the person who heads up all the kinds of connections we're doing. Catherine Gerkas is up next. Catherine, please go ahead.

Catherine Gerkas executive
#2

David, thanks, and a good morning to everyone. This call, as David noted, will review Gladstone Capital's results for both the quarter and the fiscal year that closed on September 30th, 2026. We're glad you could join us. Joining me today are our Chairman, David Gladstone; Bob Marcotte, our Chief Executive Officer; Mike McQuigg, our President; and Nicole Schaltenbrand, our Chief Financial Officer. Speaking with our shareholders and analysts and providing a company update is always something we enjoy. To begin, I'll make a brief disclosure regarding certain regulatory points. Forward-looking statements may be included in this call, and those statements depend on management's estimates, assumptions, and projections. Nothing about future performance is promised, and real outcomes may vary significantly from what these remarks state or suggest, given a range of unknowns—among them the risk factors listed in our SEC filings, which you can access through the Investors section of gladstonecapital.com. We undertake no duty to unclear. This morning Bob and Nicole will walk through several slides from the presentation. You may also register for our email alerts and locate details about reaching our Investor Relations team. I'll now hand things to Bob Marcotte, Chief Executive Officer of Gladstone Capital.

Bob Marcotte executive
#3

Thanks, Catherine, and good morning everyone — appreciate you all joining the call. Mike McQuigg is here with us this morning; he came to Gladstone in 2015 and took over as President of Gladstone Capital on October 1st, and he'll be around with Nicole and me for your questions. I'll go through the quarter's highlights and the fiscal year, explain how we invest, and walk through some of the valuation movements in the portfolio. Nicole will give you some detail on the financial results, and then I'll wrap up with the market, what we've been investing in, and our near-term outlook. Starting with last quarter, net investment income was $11 million, or 49 cents per share for the period, which matched the prior quarter. Investment balances and yields held steady, and our net interest margin came to 8.2%. Fee and dividend income of $200,000 was below historical averages, and thanks to a $480,000 incentive fee credit from our advisor, net investment income after preferred dividends covered 100% of our 45-cent regular monthly distributions; for the year, total investment income grew 11.7%, and net investment income of $2.00 per share covered our regular distributions at 104.5% after preferred dividends. Net asset value fell 73 cents to $20.77 per share for the quarter — 18 cents of that decline was the supplemental distribution we paid in September, and the rest came from unrealized depreciation of the portfolio, net of a small realized gain. Roughly two-thirds of the quarter's depreciation was on loans to two existing non-accrual investments, which brought our non-earning assets down to 2.8% of the portfolio fair value. Depreciation on several appreciated equity investments also added to the unrealized depreciation for the period, which isn't unusual, since small moves in EBITDA or market multiples can affect our equity positions. I'll dig into some of the valuation movements shortly; but I think now is a good moment to restate the underlying discipline behind our investment focus, process, and structuring, which hasn't fundamentally changed. We've been lending to the lower middle market for 25 years, and while the companies we lend to can grow relatively large, we don't compete in the broader middle market loan arena. Our borrowers are established, growth-oriented businesses with EBITDA typically under $10 million at origination, and most are backed by private equity sponsors. We see the competitive dynamics in the lower middle market as attractive, since our sources indicate roughly 80% of buyout transactions are under $100 million. On the other side, most private credit inflows are increasingly concentrated upmarket — 79% of direct lending funds raised in 2026 went to funds over $5 billion, per PitchBook, and a fund that size certainly isn't going to come down and compete with us. We do work in the wider deal market, which sits outside where most institutional capital tends to flow, and that gives us room to be choosy and disciplined about credit, secured structure, and economic terms. Almost every investment we make, we originate in-house. Each one gets treated as a business rather than a financial transaction; our diligence follows much the same path an equity investor would take, though we use what we learn to drive structuring and documentation and to serve as agent on most of our investments, and all of our loans carry financial maintenance covenants. The same team that sources and underwrites an investment stays responsible for monitoring it until exit. Because of that, we think very few of our loans overlap with those held by other public BDCs, and our credit results rest on our own underwriting and portfolio management. As evidence our approach works, over the last 10 years, on a split-adjusted basis, Glad's net investment value per share rose by $3.53, and distributions totaled $18.14 per share, a return of 1.6 times the average public BDC across that same stretch. On the credit management side, we hold board observation rights or board seats at nearly all of our portfolio companies and get monthly financials, so we can spot credit problems early and act sooner. When a business underperforms, we weigh what changes may be needed and whether putting more capital in from us would lift the recovery or simply enlarge our exposure. Last quarter, that translated into advancing capital to two of our non-earning companies while choosing not to put more money into a third. Net unrealized depreciation for the period was $13.6 million. That said, the seven biggest decliners made up $20.2 million of markdowns, while the rest of the portfolio gained a net $6.6 million. Breaking the depreciation down further, $8.7 million of the decline came from Eegee's and B&T, both on non-accrual. The bigger one is Eegee's, an Arizona restaurant business we control, and as we discussed last quarter, revenue came in weaker than expected, which lowered the value of the business, and we advanced additional capital to back the new management's plans. Unrealized depreciation on that loan was $5.5 million for the quarter. The second is B&T, a telecommunication services company on non-accrual for more than a year. We chose not to invest further and wrote the remaining $3.2 million of loan value down to zero. We expect to exit that position in the December quarter with no further impact on our NAV. On the equity side, three positions produced unrealized depreciation of $7.1 million, including a dredging contractor, an oil well driller in Texas, and a healthcare marketing services business. Earnings at each came in short of plan, but all three are operating businesses, and two of the three positions remain valued above our cost. Once you strip out the non-accrual and equity valuation items we described, the rest of the portfolio kept performing well, with nominal depreciation. At quarter end, non-earning investments stayed flat at five companies, carrying a cost basis of $52.9 million, equal to 6% of debt investments at cost, and a fair value of $23.8 million, equal to 2.8% of fair value, versus $30.6 million, or 3.6% of the portfolio at June 30th. Workouts do take time, and I won't put a date on them, but our record speaks for itself. Across the last five years, equity investments generated roughly $64.2 million of net gains, both realized and unrealized, which more than offset the $26.3 million of net losses on our loans. We continue to feel confident about the outlook for these businesses and expect them to improve in the quarters ahead. With that, I'll hand the call to Nicole for some details on fund financial results for the quarter. Nicole?

Nicole Schaltenbrand executive
#4

Appreciate that, Bob, and morning everyone. During the September quarter, our total interest income rose $100,000, reaching $24.4 million, because average earning assets were largely unchanged while the weighted average yield on the interest-bearing portfolio declined slightly to 11.7% for the period. Total investment income was $24.6 million, compared with $24.5 million the quarter before. PIK income dropped to $1.4 million in the quarter, equal to 5.7% of interest income. Total expenses were essentially unchanged at $13.6 million versus the previous quarter, as interest expense grew $300,000 owing to a full quarter of the 7% notes issued in June, net of lower average line of credit borrowings, and net base management fees went up $200,000. Offsetting those gains was a $600,000 decline in net incentive fees, and that figure reflects a $500,000 incentive fee credit during the quarter. Net investment income came to $11 million for the quarter, equal to 49 cents per share. Once $900,000 of preferred dividends is subtracted, the result was $10.2 million, which represented 100% of the regular monthly distributions declared on common shares. The 18-cent supplemental distribution paid in September was declared separately from the regular monthly rate and does not count toward that coverage. Turning to net asset value, which appears on slide nine of our investor presentation, we began the quarter at $21.50 per share. Net investment income of 49 cents, reduced by 4 cents for the preferred dividend, covered our 45 cents of regular distributions. The supplemental distribution took 18 cents off NAV. Net unrealized depreciation reduced it by 48 cents on debt investments and 13 cents on equity investments, partly offset by 6 cents of realized gains, leaving us at $20.77 as of September 30th. The net decrease in net assets from operations came to $2.2 million, or 10 cents per share, reflecting the unrealized depreciation Bob discussed earlier. For the fiscal year, total investment income rose $10.5 million, or 11.7%, reaching $99.6 million, as average earning assets climbed $121.9 million, or 17.9%, while the weighted average yield dropped to 11.9% from 12.7% the year before, largely because of lower SOFR rates. We saw a comparable increase in total expenses, driven by $5 million of interest expense tied to greater average line of credit borrowings and a shift in our debt mix. Net base management fees climbed $2.9 million thanks to higher average assets, while net incentive fees gained $1.9 million, since the incentive fee credit came in at $500,000 this year versus $2.3 million a year earlier. Net investment income for the year reached $45.1 million, or $2.00 per share, against $45.2 million, or $2.02 per share in the prior year. Once preferred dividends of $2.6 million were accounted for, net investment income for the year covered 104.5% of our regular distributions. Net unrealized depreciation for the year totaled $11.5 million, and the net increase in net assets resulting from operations reached $32 million, equal to $1.42 per share. Across the year, regular plus supplemental distributions amounted to $1.98 per share, and net asset value per share declined by $0.57. Turning to the balance sheet, total assets as of September 30th rose to $973 million, comprising $956 million of investments carried at fair value along with $17.7 million in cash and other assets. As of September 30th, our liabilities came in at $453 million, up from $439 million on June 30th, and that increase was primarily due to a higher total debt figure. At the end of the quarter, we had drawn $188 million against our $385 million credit facility, and the remainder of our liabilities consists mostly of $149.5 million in 5 7/8% notes due October 2030, $60 million in 7% notes due December 2029, and $50 million in 3 3/4% notes due in May. At quarter close, about $178 million was still available under that facility. This facility is our only floating rate borrowing, accounting for 42% of principal debt, while roughly 85% of the debt investments we hold carry floating rates. In addition, during the quarter we issued $6.8 million of our 6.25% Series A preferred stock, which carries a principal balance of $57 million. Net assets as of September 30th were down $16.4 million from June 30th, landing at $469.3 million. Debt-to-equity, counting our preferred stock, came in at 1.08 times versus 1.00 times at June 30th. Measured on principal debt alone, that figure was 0.95 times against 0.90 times at June 30th; turning to distributions, the monthly payout for November and December will be $0.15 per common share, equal to an annual run rate of $1.80 per share. The board convenes again in January to set the monthly distributions paid to common stockholders for the next quarter. Our accumulated spillover stood at roughly $5.5 million, or $0.24 per share, at September 30th. I'll now hand things back to Bob for the market discussion and our outlook.

Bob Marcotte executive
#5

Appreciate it, Nicole. Turning to the market: across the broader landscape, transaction volume tracks interest rates and economic conditions, and through most of this year it has held steady or drifted lower. The lower middle market is affected less by this, because its deal flow tends to come from family- or founder-owned companies being sold. As detailed in the investor presentation we posted last night, the lower middle market continues to show reasonably consistent acquisition multiples and moderate leverage—2.9 to 3.7 times EBITDA across the last two years—plus a solid pricing advantage for borrowers below $10 million of EBITDA, compared with the more competitive middle market. Because our investments carry only moderate leverage, smaller commercial banks do occasionally show up among participants, yet their rigid structures and slow reactions often create obstacles. Whenever rival unitranche lenders pursue appealing PE-backed opportunities, we have secured those mandates, where suitable, through two means: introducing senior lenders to lower the blended rate on the whole facility, and retaining our customary role as agent managing those credits. In mid-September, short-term rates moved up by 25 basis points, and the bulk of the impact on our earnings starts to appear in the December quarters. Since the bulk of our loans carry floating rates and over half of our borrowings are fixed, this rise—and any additional moves—would boost our net investment income. Turning to investment activity, during the fiscal year that just closed we looked at roughly 500 opportunities and completed 19 transactions. Our investing for the year came to $309 million, which included $171 million across 11 new portfolio companies. Repayments fell to $210 million from $352 million a year earlier, so the portfolio increased by $97 million. Fundings in the last quarter reached $84 million, made up of two new investments totaling $33 million plus $51 million of additional advances to existing portfolio companies during the quarter. Both of the new investments are precision manufacturing businesses with strong order backlogs. Looking at the quarter overall, average leverage on what we originated was 3.2 times EBITDA, entry loan-to-value stood at 48%, and the spread over SOFR was 730 basis points. We saw $71 million in exits and repayments, which left net originations of $13 million for the quarter. Those two exits were legacy investments tied to energy that we had expected. Within the portfolio, first-lien debt made up 74% of portfolio cost, while total debt investments accounted for 90%. With our leverage having risen, we've grown more selective about deploying new capital, favoring portfolio companies with strong performance that gain from the scale that comes with added capacity or acquisitions. After the quarter closed, we put $6.9 million into one of our existing portfolio companies to support an appealing acquisition. Going forward, we'll keep managing our late-stage deal pipeline broadly consistent with near-term repayments and liquidity events. As we reflect on fiscal 2026, which we just completed, and consider the next quarter or two, here's my key takeaway for you. Total investment income and the portfolio each grew more than 11% this year, but net investment income was essentially unchanged, driven by lower rates, increased financing costs, and higher net management fees as well. Our effort now is to get our non-earning investments back to earning status, or to recover that capital and put it to work so earnings can scale, while we keep balance sheet leverage managed around 1.1 times NAV. In October 2025 we reset the regular distribution to 15 cents per month, and since then net investment income after preferred dividends has covered it every quarter. Looking ahead, we anticipate supporting dividend coverage through a mix of fee and dividend income, by monetizing equity assets and reinvesting in earning assets, through recovery of non-earning loans, and we will consider incentive fee waivers, as the manager has done previously. Given the assets added this year and the recent rise in short-term rates, which works out to roughly 6 cents a share of NII lift, we expect coverage to remain sustainable. Ours is an investment-driven culture, and for fiscal 2027 our priority is improving net investment income per share while still delivering top-quarter economic returns to shareholders, which they have enjoyed for a decade or more now. Operator, would you please let our callers know how to ask their questions?

Mickey Schleien analyst
#6

Yes, hello everybody. Bob, I'd like to pick up on your comments about the pipeline. It feels as though people are starting to agree that M&A could pick up next year, but the way I see it, there's still a lot of uncertainty around the Fed's next moves. We've also got uncertainty economically and politically. I'd love to hear your view on deal flow for next year.

Bob Marcotte executive
#7

Morning, Mickey. The signals are clearly mixed. The SOFR forward curve is plainly rising, and that's not helpful for buyouts. Economic conditions, tariffs and similar factors have clearly produced a fair amount of ups and downs. Even so, in my view the political developments of late have set up a situation in which a regulatory roadblock, or an environment of doing nothing, is more probable. I also believe a number of these portfolio companies have grown old and the moment has come to sell, and the pressure LPs are putting on PE funds is quite substantial. In examining sale transactions—and we truly consider refinancing transactions as well as sale transactions—within the refinancing environment, a great many of our companies have achieved real growth. When I mentioned that we begin below 10, there are businesses with EBITDA in the 30 to 40 range that have scaled considerably. The market's clear recognition of their multiples has shifted, and these are generally growth-focused companies. In a tougher climate, what we observe is that firms which have expanded, which have performed, and which hold solid growth prospects will keep trading. That's roughly the first point. Second, given their scale, market opportunities exist for them to refinance. Naturally, we usually stick with the terms we set when we first originate assets, and when EBITDA ends up two, three, or four times our entry level, plenty of larger players upmarket are willing to lever that at a cheaper rate or a bigger multiple. I do believe there are several areas within our business and sectors where the growth rate alone will drive acquisition, and bigger sponsors are going to want to enter that space. A couple of examples: we have many precision manufacturing companies in our business, and these folks are experiencing substantial continuation of business being brought back to the States. They are seeing enormous amounts of spending in defense and aerospace across contracts that will grow dramatically. For the primes, consolidating so they become a bigger, more comprehensive, and more capable competitor in that business is essential if they are to keep supplying the growth in some of those end markets; we would expect that activity to be tied to a degree to particular growth sectors. We are seeing that in some of our businesses even at the scale we have, and we would expect it to continue. To be honest, I doubt that financial arbitrage—buying at elevated leverage and an inflated multiple—will turn out to be a very effective strategy in 2027, but that is not how we look at the M&A landscape. Our businesses begin at around 7 to 7.5 turns on a multiple basis. Once they reach $20 million or $30 million of EBITDA, they'll command 9 or 12 turns, depending on the industry underneath. What fundamentally drives sale transactions for our business differs considerably from the broader upmarket environment, which I believe will keep facing headwinds from fund flows; net redemptions across the private BDCs are certainly not making conditions especially strong for financing in that sector. The bottom line is that I expect the lower middle market will keep trading—that's where the bulk of transactions occur—and I feel fairly confident about our companies' position when it comes to accessing that liquidity. As I mentioned, we'll keep watching that closely as we steer our investment activities going forward.

Mickey Schleien analyst
#8

Bob, may I ask a follow-up on something you mentioned? The new originations you just reported for the quarter came at attractive spreads, but you've also discussed repayments and refinancings as portfolio companies expand. Is that too big a headwind, or do you see ways to hold steady or maybe even lift portfolio yields, regardless of the forward curve — who knows where interest rates will sit a year from now, and the forward curve is famously unreliable — so just at a high level, how are you thinking about portfolio yields?

Bob Marcotte executive
#9

Mickey, that's an interesting question. I look at it in two ways. On refinancing activity, sure, I don't think borrowers will be able to cut their cost of funds dramatically, but that isn't the only motive for refinancing; they may be nearing maturity and need an extension; they may accept a rate that's probably less attractive yet still cheaper than where we are, and they may want a distribution so they can share that money with their LPs to supply the liquidity they're clamoring for given how old some of the companies in these portfolios are. So refinancing activity may be driven more by leverage than by rate as part of their motivation. As for improving our portfolio yields, one thing we don't do is pursue financial transactions for their own sake; we're not an opportunistic lender, we're not seeking turnaround situations, we're not trying to juice our yields. Given that we're putting investments out in the low 3s on a senior secured basis and delivering spreads in the low 7s, I wouldn't want to push that too far, because we'd be taking on credit quality and might move down the capital stack and increase our risk. Overall, I'd say we're probably at the top end of our yields. The only thing we might do is perhaps more first-out facilities, bringing a bank in, which can get us somewhat better borrower pricing off the back end of those situations, but I wouldn't want to chase yields in a way that materially raises our leverage or credit risk profile, which is core to our business. The last piece I'd say is we really like attractive growth businesses. I'd rather finance a growth-oriented business at an attractive rate than stretch yield, because in many cases we'll invest in that company's equity too, and we'll get a lift on the equity side. As my comments said, we've been very successful realizing gains on our equity, and we have a number that we hope will come to fruition in 2027. Strong businesses, in addition, provide equity upside on the co-investments we make, and pursuing that is preferable, in my view, to going after a turnaround situation in which such upside may not be as evident.

Mickey Schleien analyst
#10

That is genuinely useful perspective, and I appreciate your taking the time for my questions this morning. Thank you.

Bob Marcotte executive
#11

Thanks for calling in.

Erik Zwick analyst
#12

Hello, and thanks. Morning to you. This is somewhat of a follow-up, perhaps, to what Mickey asked, just looking at where things stand right now. The futures curve seems to point toward rates climbing, though whether that actually happens remains to be seen. I'm just wondering whether you can bring us up to date as of, say, September 30th regarding the average debt service coverage ratio across your portfolio companies, and also the range?

Bob Marcotte executive
#13

Today's portfolio carries weighted average leverage of 3.7 times, while the weighted average fixed charge coverage stands at 2.5.

Erik Zwick analyst
#14

Are you all still able to hear me? My apologies — I'm on the road today and my reception has been spotty.

Bob Marcotte executive
#15

Yes.

Erik Zwick analyst
#16

Great, thank you. I suppose the sole remaining item I wanted to raise today concerns a few of those fair value movements, and I appreciate the ones you covered during the prepared remarks. I was wondering whether you could offer any additional commentary on Dutch Gold Honey, which posted a sizable gain this quarter?

Bob Marcotte executive
#17

With Dutch Gold, certain folks tend to raise questions regarding consumer trends. Dutch Gold ranks among the biggest honey distributors across the Eastern United States, and it was acquired at a fairly low multiple. The business didn't decline as much as people had anticipated; instead, it moved in the opposite direction and has kept on growing. During the transition away from the founding family, who had owned the company for 75 years, they hadn't been putting money into the plant. The sponsor that came in, whose financing we helped arrange, set out a highly detailed capital expansion plan aimed at boosting capacity and growing their customer base. They've carried out that plan and are starting to bring in extra revenues. Rather than going down, it is expanding dramatically. Multiples for food and food service-related businesses, especially those tied to healthy, appealing, natural ingredients such as honey, which is increasingly used as a substitute in all sorts of ways, keep rising. A low multiple, expansion, new customers, growth, and appreciation in the exit multiple are all coming together into a very attractive framework here. My guess is there's likely still further upside in that particular business, and I also suspect it could be one on the horizon that the sponsor would consider selling, given that they've largely recovered all of their equity and remain very much in the black.

Erik Zwick analyst
#18

I appreciate the update. Thanks for taking my questions.

Bob Marcotte executive
#19

Thank you.

Christopher Nolan analyst
#20

Hello, and thank you for what you said about the current sponsor environment. Which industry sectors do you see enjoying the strongest organic growth? The broad sense of the question is that, because a financial arbitrage really isn't available to a lot of these sponsors, they must grow their portfolio companies in order to achieve an exit. I'm just trying to get a sense of which industry sectors you see growing the most.

Bob Marcotte executive
#21

The simplest answer there would be anything downstream of data centers or fab construction. It dominates the economic landscape right now. The worry is that at some point those will slow down. Backlogs are extremely rich, and I believe through 2027 it's quite clear that those are growing. A derivative of that is likely things tied to defense or defense-related areas, and finally, I'd mention electrical infrastructure and grid-type investments. Let me offer a couple of points. Vyron in the portfolio is a business making coated stainless steel tubing and products used in fab construction. Its backlog is likely approaching more than a year. Its growth rate has more than doubled over the last year. I believe they have a solid backlog, but that's a situation where it could either refinance or sell the business; we certainly have a number of precision metal fabrication businesses supplying some of the industries I've mentioned. The missile, space and aerospace backlogs keep growing, whether we're talking gas turbines or aircraft turbines. That market is expanding dramatically, and we have probably four or five investments otherwise tied to that particular industry. Businesses have grown, backlogs are as strong as they have ever been, and their customers want more capacity to feed into that market. We're seeing a kind of multiple of plays around precision manufacturing and domestic production. What I'd say is that there's a greater level of sophistication the large end customers are seeking, whether that's production capacity, automation, new machinery, production capabilities, or specifications and detailed performance specs. All of those things require investment, and between the capital base and the sponsors we finance and their forward vision for those businesses, what we're finding is that the private equity improvements in these underlying businesses are setting themselves apart from what is a very broad base of industrial, small-scale, family-run businesses. If you're a private jet manufacturer, for example, and you have 300 suppliers, only a small smattering of those companies possess the people, the knowledge base and the wherewithal to keep expanding and improving their production capabilities. Last quarter, one of our investments happened to be the number one rated supplier to a private jet manufacturer that has supplied this company for 50 years, and thanks to our investment and some additional capital going in, they are going to give us more business because the company has an unblemished track record of delivering. There's a factor at play in these growth scenarios right now: when the right ingredients are present, you get attractive growth relative to the entry multiples for these businesses, which consistently trade in the 7, 8 times range. Thanks to both that growth and the multiple arbitrage, those investors are going to see very nice returns. I hope that helps.

Christopher Nolan analyst
#22

When it comes to industries that aren't expanding, do you expect private equity will simply try to hold on until conditions improve, or what's your view on how that plays out?

Bob Marcotte executive
#23

The zombies? What we're clearly observing is that certain businesses face greater difficulties. Our approach with those companies is that most of them approach us seeking refinancings. They've spent four or five years in the game, or perhaps they were completed in 2020 or 2021, and now the debt needs refinancing since it's reaching maturity and their business hasn't really grown. In the refinancing market, we usually decline those situations. When they sit in our portfolio and are at context, what we typically observe is that growth is absent, there's no need to invest in new capacity, no working capital requirements arise from an expanding business, and they ought to produce free cash flow, since our average portfolio carries relatively low leverage, and eventually leverage reaches a level where you ask whether we're the appropriate lender for a company with low growth. At 2.5 turns of leverage, at two turns of leverage, when our average portfolio is SOFR 7, why not approach a bank and borrow at SOFR 3.5, then capture the difference through larger distributions to the equity? We tend to view those situations as they deleverage, and naturally they'll head to the bank, and we won't pursue them since it makes no sense; for a non-growth business that's organically deleveraging, we are not the right partner.

Christopher Nolan analyst
#24

Great, thanks.

Robert Dodd analyst
#25

Hi, everybody. Regarding the topic you raised about recent political shifts, and for founder-owned businesses—well, for sponsor-owned ones too—clearly tax planning frequently plays a role in motivating a sale, a decision, some action or other. Though I don't believe any tax changes are coming imminently, if this political shift keeps going, I have to think worries about tax changes perhaps past '28 would grow. Do you figure that will speed anything up, especially perhaps within your founder-owned business target segment—maybe not what's already in your portfolio, obviously, but the opportunities? Could you see an accelerated cycle emerge from those sorts of concerns over the next couple of years?

Bob Marcotte executive
#26

For some time now, taxes really haven't been what moves transactions, in my view. There was a period when their effect mattered more. Among the majority of founders we deal with—many of them looking to separate themselves and walk away from a company they might have spent 30 or 40 years at, frequently well into their 70s—taxes probably aren't the main worry. It could be what gets them to begin the conversation, yet it isn't the reason the business gets sold. I do believe that if there's momentum toward some degree of tax increases, it could make some sense that people would give it thought, but the fundamentals behind their decision to sell carry far more weight. We examined deals in which the proprietor was in his early nineties and had been weighing whether to sell the company, and taxes truly were not the issue. The drivers were family matters, the ownership structure, and how he saw himself. Taxes might add a bit at the margin, but businesses built around a family won't be steered much by such forces. Either they have someone to take over, or they have a management team that can keep running things, and they may or may not possess the capital base required to expand the company and stay competitive in the market as I've described. Every one of those factors would generally matter more, and I don't expect that to change.

Robert Dodd analyst
#27

Understood. Thanks. So then a follow-up that's a bit unrelated. Regarding those first-out arrangements where you've been involving banks, has that market become more competitive — and if competition has increased and banks are prepared to do more, that works in your favor, correct? How satisfied are you with the terms and the structure, and with how that market — or rather how your use of it — has developed somewhat, since clearly it offers certain benefits, as you mentioned, in terms of the return to you and a lower overall debt cost for the borrower, perhaps?

Bob Marcotte executive
#28

It changes all the time, Robert. There are, I would note, a number of banks in the mid-sized or regional category that simply don't have the origination capabilities to book C&I loans on their own. One way for them to book C&I loans is to partner with an experienced creditor that has responsible management and performs diligence on their companies. Once those folks see how we approach our deals, how we underwrite our deals, and the diligence information we provide, they're frankly eager to see more transactions from us. At the same time, those businesses can be acquired, they can be merged, or they could eventually build their own origination capabilities, and so they will run it for a period of time and maybe they will transition out. Broadly speaking, we've seen a favorable shift with additional people becoming available in that market, and I don't sense any restriction on our side. Turnover is fairly continuous. The standard rates remain in place. What we offer them involves significantly lower leverage than what they'd encounter on a straightforward basis. To be candid, they lack the means to reach the buyout market and private equity sponsors in the same manner. As for our capacity to integrate them into a solution that suits the sponsors — they don't possess the knowledge, the experience, or the structuring capabilities, so they depend heavily on us to prepare them and bring them into the deals. I anticipate that opportunity will persist. For deals where we have strong conviction about performance and growth and want to be more competitive, that's generally the only situation in which we do this, and usually we bring them in with just a very modest amount of leverage. Typically those deals carry two plus or minus turns of leverage and are relatively risk-free. Should an issue ever arise, we believe we can always either pay them out or refinance them out, whichever the case may be. I see positive growth in this market, but there will always be turnovers, and you always have large-scale banks that won't do those transactions. You're working with players in the smaller category or specialized lenders that will participate in transactions alongside us.

Robert Dodd analyst
#29

Understood. That's quite useful. Thanks.

Bob Marcotte executive
#30

Thanks to everyone for the questions today and for joining us. We look forward to bringing you an update next quarter. That brings our call to a close. Many thanks.

Operator operator
#31

Thanks—that brings us to the end of today's conference. You're welcome to disconnect now, and we appreciate your participation.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Gladstone Capital Corporation transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.

Get an API key View API docs →

For developers and AI pipelines

Programmatic access to Gladstone Capital Corporation earnings transcripts and 132,000+ others is available through the EarningsAPI REST API and the hosted MCP server. Quarterly plans from $162 - full transcripts, speaker segments, full-text search, and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.